MG 012
Alternative Names: MG-012Latest Information Update: 07 Jun 2022
At a glance
- Originator Shanghai Mabgeek Biotech
- Class Monoclonal antibodies; Urologics
- Mechanism of Action Immunomodulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research Kidney disorders; Respiration disorders
Most Recent Events
- 25 May 2022 Early research in Kidney disorders in China (Parenteral)(Shanghai Mabgeek Biotechnology pipeline, May 2022)
- 25 May 2022 Early research in Respiration disorders in China (Parenteral)(Shanghai Mabgeek Biotechnology pipeline, May 2022)